MMP9 and hepatocellular carcinoma: High protein levels of MMP-9, VEGF, MCL-1, XIAP, C-FLIP, and Cyclin-D1 have been suggested as biomarkers for poor prognosis and these proteins are potential therapeutic targets for the development of anticancer treatments in patients with HCC [15–18].